Diagnostic Regional Medical Lead, Oncology Breast - ...

Join a Legacy of Innovation 110 Years and Counting!Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group''s 2025 Vision to become a ''Global Pharma Innovator with Competitive Advantage in Oncology,'' Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.Job SummaryThe Diagnostic Regional Medical Lead (Director Level) is a hybrid headquarters and field-based position that will provide diagnostic leadership of the Medical Diagnostic strategy and have field-based liaison responsibilities supporting the Southeast region of the US (TN, NC, SC, MS, AL, GA, FL). This role will collaborate with relevant business partners to develop, align and execute the Medical Diagnostic strategy with external stakeholders. The candidate will identify and develop on-going professional relationships with key national and regional leaders in the diagnostic and biomarker areas in select oncology tumor types. Additionally, the Principal Medical Diagnostics Liaison, Pathology develops skills and competencies to educate healthcare professionals and DSI internal stakeholders, including but not limited to Clinical Development, Clinical Development Operations, Medical Research and Strategy, Commercial, Biomarkers and Companion Diagnostics (CDx).Commercial, Biomarkers and Companion Diagnostics (CDx).ResponsibilitiesScientific Engagement:Support strategy development and own the execution of biomarker diagnostic readiness programs (launch plans and budgets)Develop external engagement strategy, facilitate engagements and build relationships with key leaders in the diagnostic and biomarker area, including clinical experts and specialized pathologistsEstablish and foster working relationships with CAP, USCAP, ASCP, and regional pathology societiesIdentify opportunity and selectively manage relationships with strategic partners, including advocacy, payer and provider groupsRecommend and deliver diagnostics-focused educational content targeted to KMEs in the diagnostic and biomarker areas (primarily pathologists)Identify and appropriately facilitate external engagement related to biomarker evidence generation plansDrive dedicated pathology-centered trainings according to interpretation guides and ASCO/CAP guidelines; perform in person and virtual slide reviewsEducate on clinical risk mitigation and impact of diagnostic choice on patient managementGather pathology-related external medical insights regarding DSI investigational products to help inform Clinical Development and US Medical strategyRespond to unsolicited requests for medical informationStrategic Planning and Project Management:Evaluate and contribute expertise to the US diagnostic strategy for current and future DSI oncology productsCollaborate with relevant internal business partners (e.g., HEOR, HOL) to assist with design and execution of HEOR studies, outcomes surveys, etc. related to diagnosticsIdentify and assist in leading solution-based strategies to address biomarker adoption, barriers, and gapsLead special projects/initiatives, as needed, in support of US Medical Affairs diagnostics strategyQualificationsThe successful candidate will be able to meet the qualifications below with or without reasonable accommodationEducation/ExperienceQualified candidates will have the following: Advanced scientific degree (PhD, PharmD or MD) preferred; equivalent will be considered with relevant experience in diagnostic and biomarker areaAt least 5+ years of related work experience in industry, clinical, or research institution with emphasis in pathology Strong business acumen, including understanding of drivers behind evolving diagnostic landscapeStrong analytical and problem-solving skills while demonstrating strategic thinking, leading, and delivering outcomesDeep understanding of diagnostic FDA environment, clinical laboratory practices including CAP/CLIA lab requirements and test implementationProven track record of strategic thinking, judgment, and influencing skillsAbility to independently lead, initiate, manage, develop, and deliver initiatives/projectsStrong knowledge of medical strategy, clinical diagnostic development, and Field Medical activitiesClear demonstration of effective cross-functional project team collaborationProven ability to interact productively with both commercial and scientific / medical colleaguesDemonstrated experience with developing and executing strategic plansDemonstrated leadership abilities in a matrix organizationExperience in engaging with external expertsExceptional teamwork and collaboration skillsExcellent written and oral communication, interpersonal, and organization skills.Ability to travel up to 50% of the time, including overnight.Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Created: 2021-11-29